Safety and Feasibility Trial of Adipose-Derived Regenerative Cells in the Treatment of Chronic Myocardial Ischemia

Completed · Phase 2 · Has a placebo group

Conditions studied: Myocardial Ischemia

In brief

This is a prospective, randomized, placebo-controlled, double blind safety and feasibility clinical trial.

Key facts

Study ID

NCT01556022

Run by

Cytori Therapeutics

People needed

28

Starts

2012-06-01

Expected to finish

2016-10-01

Last updated by the study team

2016-10-28

Who can join

Age: 20 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Cardiology, P.C. — Birmingham, Alabama, United States
• Scripps Clinic - Torrey Pines, Scripps Green Hospital — La Jolla, California, United States
• University of Florida — Gainesville, Florida, United States
• Florida Hospital-Pepin Heart Institute — Tampa, Florida, United States
• Minneapolis Heart Institute Foundation — Minneapolis, Minnesota, United States
• Duke University Hospital — Durham, North Carolina, United States
• Texas Heart Institute — Houston, Texas, United States
• University of Utah Health Care — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.